Recently, a study using the novel small molecule inhibitor for ALDH1A, CM37, demonstrated that ALDH1 inhibition in ovarian cancer cell lines caused a significant increase in reactive oxygen species (ROS) 18. This evidence concerns the gene ALDH1A1 and ovarian carcinoma.